Agilent Technologies (A) to Acquire BIOVECTRA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Jefferies Reiterates Hold Rating on Agilent (A)
July 22, 2024 12:42 PM EDTJefferies analyst Brandon Couillard reiterated a Hold rating and $135.00 price target on Agilent (NYSE: A).
The analyst comments "Agilent's move to acquire BIOVECTRA ($925M, or ~7x '24 revenues) would expand exposure to specialized CDMO market, adding PDNA, mRNA and HPAPI capabilities to... More
